Published in
American Association for the Advancement of Science, Science Translational Medicine, 551(12), 2020
DOI: 10.1126/scitranslmed.aaz5683
Links
Tools
PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity
Journal article published in 2020 by
Hyungsoo Kim 
,
Heejung Kim,
Yongmei Feng,
Yan Li,
Hironari Tamiya ,
Stefania Tocci,
Ze’ev A. Ronai
,
Heejung Kim,
Yongmei Feng,
Yan Li,
Hironari Tamiya ,
Stefania Tocci,
Ze’ev A. Ronai
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
PRMT5 expression in melanoma suppresses inflammation and antigen presentation, suggesting that its inhibition could potentiate immunotherapy.